Editorial: Approaches to Address Resistance, Drug Discovery, and Vaccine Development in Mycobacterium tuberculosis: Challenges and Opportunities

Editorial: Approaches to Address Resistance, Drug Discovery, and Vaccine Development in Mycobacterium tuberculosis: Challenges and Opportunities

Bibliographic Details
Main Authors:	Sandeep Sharma, Divakar Sharma, Nitin Pal Kalia
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Series:	Frontiers in Microbiology
Subjects:	Mycobacterium tuberculosis drug discovery vaccine development drug resistance resistance markers
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2022.871464/full

Similar Items

Editorial: Drug-resistant Mycobacterium tuberculosis
by: Helena I. M. Boshoff, et al.
Published: (2023-05-01)

How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery
by: Amala Bhagwat, et al.
Published: (2022-09-01)

Phenotypic and genomic comparison of Mycobacterium aurum and surrogate model species to Mycobacterium tuberculosis: implications for drug discovery
by: Amine Namouchi, et al.
Published: (2017-07-01)

Vaccine-induced Immunity Circumvented by Typical Mycobacterium tuberculosis Beijing Strains
by: Kristin Kremer, et al.
Published: (2009-02-01)

Drug-resistant Mycobacterium tuberculosis, Taiwan
by: Ruwen Jou, et al.
Published: (2006-05-01)

The spectrum of primary drug resistance of Mycobacterium tuberculosis in patients with tuberculosis in relation to human immunodeficiency virus status
by: V N Zimina, et al.
Published: (2017-11-01)

Structure-based in silico approaches for drug discovery against Mycobacterium tuberculosis
by: Alexander D.H. Kingdon, et al.
Published: (2021-01-01)

Insight Into Novel Anti-tuberculosis Vaccines by Using Immunoinformatics Approaches
by: Zafran Khan, et al.
Published: (2022-06-01)

Characterization of resistance profile of Mycobacterium tuberculosis isolates from patients with tuberculosis in Beira, Sofala - Mozambique
by: Evangelina Inácio Namburete, et al.
Published: (2016-11-01)

The Patterns of Conversion to Anti-Tuberculosis Drug Resistance in Mycobacterium tuberculosis
by: Moo-Sang Chong, et al.
Published: (2022-06-01)

Mycobacterium tuberculosis Molecular Determinants of Infection, Survival Strategies, and Vulnerable Targets
by: Davide M. Ferraris, et al.
Published: (2018-02-01)

State-of-the-art strategies to prioritize Mycobacterium tuberculosis drug targets for drug discovery using a subtractive genomics approach
by: Adetutu Akinnuwesi, et al.
Published: (2023-09-01)

The Study of the Possible Program-related Factors Contributing to Drug Resistance in Tuberculosis Patients
by: Hareesh Pathak, et al.
Published: (2023-06-01)

Drug Resistance Mechanisms in Mycobacterium tuberculosis
by: Juan Carlos Palomino, et al.
Published: (2014-07-01)

Mycobacterium tuberculosis Drug Resistance, Ghana
by: Ellis Owusu-Dabo, et al.
Published: (2006-07-01)

Search for Antimicrobial Activity Among Fifty-Two Natural and Synthetic Compounds Identifies Anthraquinone and Polyacetylene Classes That Inhibit Mycobacterium tuberculosis
by: Luiz A. E. Pollo, et al.
Published: (2021-01-01)

Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery
by: Antonia Molloy, et al.
Published: (2021-11-01)

Pattern of drug resistance of Mycobacterium tuberculosis clinical isolates to first-line antituberculosis drugs in pulmonary cases
by: Deepika Kalo, et al.
Published: (2015-01-01)

Increasing Drug Resistance of Mycobacterium tuberculosis Isolates in a Medical Center in Northern Taiwan
by: Wei-Juin Su, et al.
Published: (2008-03-01)

Resistencia a drogas de segunda línea en cepas peruanas de Mycobacterium tuberculosis multidrogorresistentes
by: Francesca Barletta, et al.

GeneChip analysis of resistant Mycobacterium tuberculosis with previously treated tuberculosis in Changchun
by: Ming-Jin Zhang, et al.
Published: (2018-05-01)

Development of Delpazolid for the Treatment of Tuberculosis
by: Young Lag Cho, et al.
Published: (2020-03-01)

PHYLOGENY MAGNITUDE OF Mycobacterium tuberculosis BASED ON GENOMIC ANALYSIS
by: Budi Yanti, et al.
Published: (2020-08-01)

Drug Resistance in Mycobacterium Tuberculosis Isolates to Isoniazid and Rifampin
by: M Pourhajibagher, et al.
Published: (2012-05-01)

Drug resistance profiles of Mycobacterium tuberculosis isolates to first line anti-tuberculous drugs: A five years study
by: Sarala Menon, et al.
Published: (2012-01-01)

Identification of putative biomarkers for the serodiagnosis of drug-resistant <it>Mycobacterium tuberculosis</it>
by: Zhang Lu, et al.
Published: (2012-02-01)

Drug resistance-conferring mutations in Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia
by: Mulualem Tadesse, et al.
Published: (2016-01-01)

Beijing strains of Mycobacterium tuberculosis in smear-positive tuberculosis patients in North-West and West of Iran
by: Leyla Sahebi, et al.
Published: (2016-01-01)

Vigilancia de la resistencia del Mycobacterium tuberculosis a los fármacos antituberculosos, Colombia 2004-2005
by: María Consuelo Garzón, et al.
Published: (2008-09-01)

Molecular Diversity of Drug Resistant Mycobacterium Tuberculosis Strains in Western Turkey
by: Hörü Gazi, et al.
Published: (2012-06-01)

Biohazard levels and biosafety protection for Mycobacterium tuberculosis strains with different virulence
by: Yinghua Xu, et al.
Published: (2020-09-01)

Plasmid-based controls to detect rpoB mutations in Mycobacterium tuberculosis by quantitative polymerase chain reaction-high-resolution melting
by: Joas Lucas da Silva, et al.
Published: (2013-02-01)

Plasmid-based controls to detect rpoB mutations in Mycobacterium tuberculosis by quantitative polymerase chain reaction-high-resolution melting
by: Joas Lucas da Silva, et al.
Published: (2013-02-01)

Assess drug resistance pattern and genetic profile of Mycobacterium tuberculosis clinical isolates by molecular typing methods using direct repeats and IS6110 in pulmonary tuberculosis cases
by: Deepika Kalo, et al.
Published: (2017-01-01)

Multi-Omics Technologies Applied to Tuberculosis Drug Discovery
by: Aaron Goff, et al.
Published: (2020-07-01)

Metabolic Rewiring of <i>Mycobacterium tuberculosis</i> upon Drug Treatment and Antibiotics Resistance
by: Biplab Singha, et al.
Published: (2024-01-01)

Highly Sensitive Detection of Isoniazid Heteroresistance in Mycobacterium Tuberculosis by Droplet Digital PCR
by: Zheng Y, et al.
Published: (2022-10-01)

Genome-wide analysis of Mycobacterium tuberculosis polymorphisms reveals lineage-specific associations with drug resistance
by: Yaa E. A. Oppong, et al.
Published: (2019-03-01)

MYCOBACTERIUM TUBERCULOSIS VIRULENCE
by: B. I. Vishnevskiy, et al.
Published: (2015-02-01)

Mycobacterial genomics and structural bioinformatics: opportunities and challenges in drug discovery
by: Vaishali P. Waman, et al.
Published: (2019-01-01)